These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30258795)

  • 21. Dermoscopic Aspects of Cutaneous Adverse Drug Reactions.
    Rossi G; da Silva Cartell A; Marchiori Bakos R
    Dermatol Pract Concept; 2021 Jan; 11(1):e2021136. PubMed ID: 33614215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous drug reactions in patients admitted to the dermatology unit at the University Hospital of the West Indies, Kingston, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2009 Jun; 58(3):227-30. PubMed ID: 20043529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous drug reactions in children: a multicentric study.
    Dilek N; Özkol HU; Akbaş A; Kılınç F; Dilek AR; Saral Y; Metin A; Çalka Ö
    Postepy Dermatol Alergol; 2014 Dec; 31(6):368-71. PubMed ID: 25610351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study.
    Barvaliya M; Sanmukhani J; Patel T; Paliwal N; Shah H; Tripathi C
    J Postgrad Med; 2011; 57(2):115-9. PubMed ID: 21654132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe cutaneous adverse reactions: A 5-year retrospective study at Hospital Melaka, Malaysia, from December 2014 to February 2020.
    Tee CT; Abdullah NH; Kristummoonthy P; Lee CS
    Med J Malaysia; 2022 Jul; 77(4):409-414. PubMed ID: 35902928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. General characteristics, economic burden, causative drugs and medical errors associated with medical damage litigation involving severe cutaneous adverse drug reactions in China.
    Zheng ZQ; Jiang C; Yu RL; Zhou JQ; Wu ZJ; Luo JY
    J Clin Pharm Ther; 2020 Oct; 45(5):1087-1097. PubMed ID: 32516456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of cutaneous adverse drug reactions at a tertiary center in Jammu, India.
    Sharma R; Dogra D; Dogra N
    Indian Dermatol Online J; 2015; 6(3):168-71. PubMed ID: 26009710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical study of cutaneous drug eruptions in 200 patients.
    Patel RM; Marfatia YS
    Indian J Dermatol Venereol Leprol; 2008; 74(4):430. PubMed ID: 18810845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cutaneous adverse drug reactions].
    Lebrun-Vignes B; Valeyrie-Allanore L
    Rev Med Interne; 2015 Apr; 36(4):256-70. PubMed ID: 25458866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stevens-johnson Syndrome and Toxic Epidermal Necrolysis: An Overview of Diagnosis, Therapy Options and Prognosis of Patients.
    Garg VK; Buttar HS; Bhat SA; Ainur N; Priya T; Kashyap D; Tuli HS
    Recent Adv Inflamm Allergy Drug Discov; 2023; 17(2):110-120. PubMed ID: 37605396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse cutaneous drug reactions among hospitalized patients: five year surveillance.
    Turk BG; Gunaydin A; Ertam I; Ozturk G
    Cutan Ocul Toxicol; 2013 Mar; 32(1):41-5. PubMed ID: 22812902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse drug reactions and organ damage: The skin.
    Marzano AV; Borghi A; Cugno M
    Eur J Intern Med; 2016 Mar; 28():17-24. PubMed ID: 26674736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe cutaneous adverse drug reactions: a clinicoepidemiological study.
    Sasidharanpillai S; Riyaz N; Khader A; Rajan U; Binitha MP; Sureshan DN
    Indian J Dermatol; 2015; 60(1):102. PubMed ID: 25657416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Retrospective Study of Drug Induced Cutaneous Adverse Reactions (CADR) in Patients Attending Tertiary Care Hospital.
    Doshi K; Yegnanarayan R; Gokhale N
    Curr Drug Saf; 2016 Jul; ():. PubMed ID: 27457767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse Skin Reactions with Antiepileptic Drugs Using Korea Adverse Event Reporting System Database, 2008-2017.
    Kim HK; Kim DY; Bae EK; Kim DW
    J Korean Med Sci; 2020 Feb; 35(4):e17. PubMed ID: 31997613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiological study of severe cutaneous adverse drug reactions in a city district of China.
    Li LF; Ma C
    Clin Exp Dermatol; 2006 Sep; 31(5):642-7. PubMed ID: 16901302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An observational study of severe cutaneous adverse reactions at a tertiary care teaching hospital.
    Lekshmipriya K; Pradeesh A; Vasudevan B; Dash M; Sood A; Gera V
    Med J Armed Forces India; 2023 Dec; 79(Suppl 1):S209-S216. PubMed ID: 38144617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Profile and Comparison of Causality Assessment Tools in Cutaneous Adverse Drug Reactions.
    Beniwal R; Gupta LK; Khare AK; Mittal A; Mehta S; Balai M
    Indian Dermatol Online J; 2019; 10(1):27-33. PubMed ID: 30775295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Wolkenstein P; Chosidow O; Fléchet ML; Robbiola O; Paul M; Dumé L; Revuz J; Roujeau JC
    Contact Dermatitis; 1996 Oct; 35(4):234-6. PubMed ID: 8957644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutaneous adverse drug reactions: clinical pattern and causative agents--a 6 year series from Chandigarh, India.
    Sharma VK; Sethuraman G; Kumar B
    J Postgrad Med; 2001; 47(2):95-9. PubMed ID: 11832597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.